NCT00991159
- Conditions
- Dyslipidemias, Healthy, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Miami Gardens, Florida, United States
Clinical trial condition
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
NCT00991159
NCT01185795
Not specified
NCT01056549
NCT01625442
NCT01384058
NCT00637078
NCT01182818
NCT01618825
NCT01618760
NCT01614561
Not specified